f8k092513_soligenix.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):    September 25, 2013    

Commission File No. 000-16929
 
Soligenix, Inc.
(Exact name of small business issuer as specified in its charter)
 
DELAWARE
  
41-1505029
(State or other jurisdiction of incorporation or organization)
  
(I.R.S. Employer Identification Number)
     
29 Emmons Drive,
Suite C-10
Princeton, NJ
  
 
 
08540
(Address of principal executive offices)
  
(Zip Code)
 
(609) 538-8200
(Issuer’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 7.01                      Regulation FD Disclosure.

Soligenix, Inc. (the “Company”) has updated its corporate presentation as of September 25, 2013.  The slides from this presentation are attached hereto as Exhibit 99.1.  The attached materials have also been posted on the Company’s website at www.soligenix.com.  The Company does not undertake to update this presentation.

Item 9.01                      Financial Statements and Exhibits.
 
(d)                  Exhibits
 
Exhibit No.
  
Description
     
99.1   Corporate Presentation.
 
 
 
 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Soligenix, Inc.
 
 
By:
 /s/ Christopher J. Schaber 
September 27, 2013 
  
Christopher J. Schaber, Ph.D.
President and Chief Executive Officer
(Principal Executive Officer)
 
 
 
 
 
 
 
EXHIBIT INDEX

Exhibit No.
  
Description
     
99.1   Corporate Presentation.